Blumenkranz Mark S.
Transaction: 08/10/2026
OTHER
Change
0
Price
Not reported
Filing
08/12/2026
Type
OTHER
Annexon, Inc.
ANNX • Biotechnology
$4.87
▲ +0.03 (+0.62%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$978.89M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.12Healthy liquidity · 5.68Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.87
Change0.62%
Shares Out201.00M
Market Cap$978.89M
Enterprise Value$794.29M
52W Range2.03 - 7.18
Beta1.22
P/E-4.83
P/B5.26
P/FCF-5.07
EV/EBITDA-3.89
EV/FCF-4.11
Price$4.87
Change0.62%
Shares Out201.00M
Market Cap$978.89M
Enterprise Value$794.29M
52W Range2.03 - 7.18
Beta1.22
P/E-4.83
P/B5.26
P/FCF-5.07
EV/EBITDA-3.89
EV/FCF-4.11
Earnings Yield-20.70%
FCF Yield-19.74%
Dividend Yield0.25%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.12
Current Ratio5.68
Quick Ratio5.68
Target$10.50
Target Upside115.61%
Target Median$10.50
Target Range7.00 - 14.00
Volume3.08M
Avg Volume3.18M
EPS Surprise0.07
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
73/100
Why this score▼
Manageable debt level · 0.12Healthy liquidity · 5.68Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
95/100
Bullish
Bullish
10
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$7.00
Mean
$10.50
Median
$10.50
High
$14.00
Insider Transactions
Recent executive and insider activity
Blumenkranz Mark S.
Transaction: 08/10/2026
BUY
Change
+175,000
Price
$5.39
Filing
08/12/2026
Type
BUY
Yednock Ted
Transaction: 06/11/2026
SELL
Change
-30,646
Price
$1.85
Filing
06/15/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Blumenkranz Mark S. | OTHER | 0 | Not reported | 08/10/2026 | 08/12/2026 |
| Blumenkranz Mark S. | BUY | +175,000 | $5.39 | 08/10/2026 | 08/12/2026 |
| Yednock Ted | SELL | -30,646 | $1.85 | 06/11/2026 | 06/15/2026 |
| Yednock Ted | BUY | +30,646 | $1.85 | 06/11/2026 | 06/15/2026 |
| Carson William H. | BUY | +65,000 | $4.70 | 06/11/2026 | 06/15/2026 |
| Choi Jung | BUY | +65,000 | $4.70 | 06/11/2026 | 06/15/2026 |
| Cockroft Bettina M. | BUY | +65,000 | $4.70 | 06/11/2026 | 06/15/2026 |
| JONES WILLIAM A JR | BUY | +65,000 | $4.70 | 06/11/2026 | 06/15/2026 |
| Satter Muneer A | BUY | +65,000 | $4.70 | 06/11/2026 | 06/15/2026 |
| Waddill William D. | BUY | +65,000 | $4.70 | 06/11/2026 | 06/15/2026 |
| Satter Muneer A | BUY | +613,497 | $5.41 | 05/28/2026 | 05/29/2026 |
| Carson William H. | BUY | +8,000 | $5.78 | 05/11/2026 | 05/13/2026 |
| Carson William H. | BUY | +8,000 | $6.20 | 04/10/2026 | 04/14/2026 |
| Carson William H. | BUY | +8,000 | $5.67 | 03/10/2026 | 03/12/2026 |
| Lew Jennifer | SELL | -5,565 | $5.42 | 03/02/2026 | 03/04/2026 |
| ARTIS DEAN RICHARD | SELL | -5,894 | $5.43 | 03/02/2026 | 03/04/2026 |
| Yednock Ted | SELL | -5,566 | $5.42 | 03/02/2026 | 03/04/2026 |
| Overdorf Michael | SELL | -4,339 | $5.42 | 03/02/2026 | 03/04/2026 |
| Dananberg Jamie | SELL | -5,820 | $5.43 | 03/02/2026 | 03/04/2026 |
| Lew Jennifer | BUY | +62,500 | Not reported | 02/19/2026 | 02/23/2026 |